☰

Sandra Scheuer - Publications

Affiliations: 
2014-2018 Max Planck Institute for Psychiatry Munich 
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ising M, Maccarrone G, Brückl T, Scheuer S, Hennings J, Holsboer F, Turck CW, Uhr M, Lucae S. FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. International Journal of Molecular Sciences. 20. PMID 30678080 DOI: 10.3390/Ijms20030485  0.52
2019 Ising M, Scheuer S, Belcredi P, Uhr M, Holsboer F. Perspective of personalised drug treatment in depression European Neuropsychopharmacology. 29: S46-S47. DOI: 10.1016/J.Euroneuro.2018.11.1019  0.564
2015 Breitenstein B, Scheuer S, Brückl TM, Meyer J, Ising M, Uhr M, Holsboer F. Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. Journal of Psychiatric Research. 73: 86-95. PMID 26704739 DOI: 10.1016/J.Jpsychires.2015.11.010  0.337
2015 Scheuer S, Ising M, Uhr M, Otto Y, von Klitzing K, Klein AM. FKBP5 polymorphisms moderate the influence of adverse life events on the risk of anxiety and depressive disorders in preschool children. Journal of Psychiatric Research. 72: 30-36. PMID 26521051 DOI: 10.1016/J.Jpsychires.2015.10.009  0.549
2015 White LO, Klein AM, Kirschbaum C, Kurz-Adam M, Uhr M, Müller-Myhsok B, Hoffmann K, Sierau S, Michel A, Stalder T, Horlich J, Keil J, Andreas A, Resch L, Binser MJ, ... ... Scheuer S, et al. Analyzing pathways from childhood maltreatment to internalizing symptoms and disorders in children and adolescents (AMIS): a study protocol. Bmc Psychiatry. 15: 126. PMID 26058452 DOI: 10.1186/S12888-015-0512-Z  0.38
2014 Breitenstein B, Scheuer S, Holsboer F. Are there meaningful biomarkers of treatment response for depression? Drug Discovery Today. 19: 539-61. PMID 24561326 DOI: 10.1016/J.Drudis.2014.02.002  0.475
2014 Breitenstein B, Scheuer S, Pfister H, Uhr M, Lucae S, Holsboer F, Ising M, Brückl TM. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. Cns Spectrums. 19: 165-75. PMID 23880209 DOI: 10.1017/S1092852913000436  0.44
2012 Breitenstein B, Scheuer S, Pfister H, Rosenhagen M, Uhr M, Nickel T, Lucae S, Ising M, Brueckl T. P.2.a.004 The clinical utility of ABCB1 genotyping in antidepressant treatment European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70333-4  0.315
2012 Breitenstein B, Scheuer S, Pfister H, Uhr M, Lucae S, Ising M, Brueckl T. P.1.a.004 CRHR1 and ABCB1 modulate sleep disturbance in depression European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70216-X  0.44
Show low-probability matches.